Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 09/16 03:52:38 pm
120.535 USD   -0.40%
09/13INSIDER SELL : Edwards Lifesciences
MT
09/09INSIDER SELL : Edwards Lifesciences
MT
09/08EDWARDS LIFESCIENCES CORPORATION : The underlying trend is in force again
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Edwards Lifesciences Raises Annual Sales Guidance

07/29/2021 | 04:40pm EDT

By Maria Armental

Edwards Lifesciences Corp. raised sales projections for the year, following stronger-than-expected second-quarter results.

The company now expects $5.2 billion to $5.4 billion in sales, up from its previous view of $4.9 billion to $5.3 billion in sales, and expects adjusted profit at the high end of the previous range of $2.07 to $2.27 a share.

This quarter, the medical-device company expects 50 cents to 56 cents a share in adjusted profit and $1.29 billion to $1.37 billion in sales, compared with analysts' projected 55 cents a share in profit and $1.3 billion in sales, according to FactSet.

"As patients and clinicians increasingly recognize the significant benefits of our less-invasive therapies, supported by the growing body of compelling evidence, we remain optimistic about the long-term growth opportunity," Chief Executive Michael A. Mussallem said in a statement.

Write to Maria Armental at maria.armental@wsj.com

(END) Dow Jones Newswires

07-29-21 1639ET

All news about EDWARDS LIFESCIENCES CORPORATION
09/13INSIDER SELL : Edwards Lifesciences
MT
09/09INSIDER SELL : Edwards Lifesciences
MT
09/05HOUSTON WE HAVE : Edwards Lifesciences to Fund Houston We Have's Clinical Trial ..
MT
08/03EDWARDS LIFESCIENCES : Goldman Sachs Adjusts Edwards Lifesciences' Price Target ..
MT
08/02EDWARDS LIFESCIENCES : Raymond James Adjusts Edwards Lifesciences' Price Target ..
MT
08/02EDWARDS LIFESCIENCES : initiates $100 million social impact investment fund to a..
PU
07/30EDWARDS LIFESCIENCES : Management's Discussion and Analysis of Financial Conditi..
AQ
07/30TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on Ma..
CI
07/30TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on Ma..
CI
07/30EDWARDS LIFESCIENCES : Oppenheimer Adjusts Edwards Lifesciences PT to $120 From ..
MT
More news
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
More recommendations
Financials (USD)
Sales 2021 5 341 M - -
Net income 2021 1 422 M - -
Net cash 2021 1 542 M - -
P/E ratio 2021 52,7x
Yield 2021 -
Capitalization 75 435 M 75 435 M -
EV / Sales 2021 13,8x
EV / Sales 2022 12,3x
Nbr of Employees 14 900
Free-Float 96,6%
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | EW | US28176E1082 | MarketScreener
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 121,02 $
Average target price 117,83 $
Spread / Average Target -2,64%
EPS Revisions
Managers and Directors
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Todd J. Brinton Chief Scientific Officer & VP-Advanced Technology
Nicholas J. Valeriani Independent Director
Kieran Thomas Gallahue Independent Director
Sector and Competitors
1st jan.Capi. (M$)
EDWARDS LIFESCIENCES CORPORATION32.57%75 435
DANAHER CORPORATION45.89%232 203
THERMO FISHER SCIENTIFIC20.74%221 479
INTUITIVE SURGICAL, INC.27.80%124 407
SIEMENS HEALTHINEERS AG35.78%75 605
ILLUMINA, INC.21.59%65 997